SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (2252)12/8/2000 1:36:10 PM
From: nigel bates  Respond to of 52153
 
However, if the same people and funds who own the PC stocks also own some biotech stocks, then the biotechs will tend to fall in sympathy.

Probably to no great extent, otherwise we would all be considerably more wealthy than we actually are....

nig



To: Biomaven who wrote (2252)12/8/2000 2:26:09 PM
From: tom pope  Read Replies (1) | Respond to of 52153
 
TSC is worth the modest subscription, but it can be pretty superficial and the two "columnists" who specialize in biotech (Luskin and Morgenthaler) are probably the most superficial of the bunch.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News